Table 2.
SN | Plasma DNA + | B cell DNA + | FFPE DNA + |
---|---|---|---|
1 | X, C | X, C, S, A | X |
2 | X, C | C, S | — |
3 | C | C, E | NA |
4 | X*, C, A | X*, P, S, E, A | — |
5 | X, C, A | C, S, A | — |
6 | C* | X, P, C*, E, A | NA |
7 | S* | X, S* | NA |
8 | C, A* | C, E, A* | NA |
9 | C, A | C, E | E |
10 | C | E | E |
11 | C, S, A | — | X, C |
12 | X | NA | X |
13 | S | C | S, X |
14 | X, C | C | NA |
15 | C | P, C | NA |
16 | — | X*, P, E, A | X* |
17 | X | X, E | C |
18 | X, C | X | C |
19 | X | S | X,C |
20 | X* | X*,S | — |
Regions within X gene (X), Polymerase gene (P), Core gene (C), surface gene (S), region spanning X & precore (A), cccDNA (E). *Genes across compartments that could not be sequenced due to faint gel band, library failure, DNA poor quality or degraded. S.N. 1 - only patient where we could successfully amplify same gene across 3 compartments (X).